| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |